 CARMIEL, Israel , June 28, 2021 PRNewswire -- Protalix BioTherapeutics, Inc. NYSE American:PLX TASE:PLX, a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today announced that Dror Bashan, the Companys President and Chief Executive Officer along with Eyal Rubin, the Companys Chief Financial Officer, will participate in a fireside chat discussion hosted by Zacks Investment Researchs John Vandermosten. The event will be held virtually on the Zoom platform, and management invites investors to participate via the webcast and conference details below: Webcast Details: Wednesday, June 30, 2021, 9:00 a.m. 